Welcome to Current Immunology, Today is
Tripterygium glycosides ameliorates ulcerative colitis through the NLRP3/Caspase-1 signaling pathway
JIANG Xintong, XU Jiaqi, YUE Jianru
Current Immunology . 2026, (1): 78 -84 .